1Davies, NP & Morland, AB (2004) Macular pigments: their characteristics and putative role. Prog Retin Eye Res 23, 533–559.
2Landrum, JT, Bone, RA & Kilburn, MD (1997) The macular pigment: a possible role in protection from age-related macular degeneration. Adv Pharmacol 38, 537–556.
3Wu, J, Seregard, S & Algvere, PV (2006) Photochemical damage of the retina. Surv Ophthalmol 51, 461–481.
4Seddon, JM, Ajani, UA, Sperduto, RD, et al. (1994) Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye disease case-control study group. JAMA 272, 1413–1420.
5Trumbo, PR & Ellwood, KC (2006) Lutein and zeaxanthin intakes and risk of age-related macular degeneration and cataracts: an evaluation using the Food and Drug Administration's evidence-based review system for health claims. Am J Clin Nutr 84, 971–974.
6Beatty, S, Murray, IJ, Henson, DB, et al. (2001) Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci 42, 439–446.
7Berendschot, TTJM, Willemse-Assink, JJM, Bastiaanse, M, et al. (2002) Macular pigment and melanin in age-related maculopathy in a general population. Invest Ophthalmol Vis Sci 43, 1928–1932.
8Bone, RA, Landrum, JT, Mayne, ST, et al. (2001) Macular pigment in donor eyes with and without AMD: a case-control study. Invest Ophthalmol Vis Sci 42, 235–240.
9Nolan, JM, Stack, J, O'Donovan, O, et al. (2007) Risk factors for age-related maculopathy are associated with a relative lack of macular pigment. Exp Eye Res 84, 61–74.
10Kanis, MJ, Berendschot, TTJM & van Norren, D (2007) Influence of macular pigment and melanin on incident early AMD in a white population. Graefes Arch Clin Exp Ophthalmol 245, 767–773.
11Hammond, BR, Johnson, EJ, Russell, RM, et al. (1997) Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci 38, 1795–1801.
12Berendschot, TTJM, Goldbohm, RA, Klöpping, WA, et al. (2000) Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci 41, 3322–3326.
13Bone, RA, Landrum, JT, Guerra, LH, et al. (2003) Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr 133, 992–998.
14Trieschmann, M, Beatty, S, Nolan, JM, et al. (2007) Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Exp Eye Res 84, 718–728.
15Koh, HH, Murray, IJ, Nolan, D, et al. (2004) Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study. Exp Eye Res 79, 21–27.
16Plat, J & Mensink, RP (2001) Effects of diets enriched with two different plant stanol ester mixtures on plasma ubiquinol-10 and fat-soluble antioxidant concentrations. Metabolism 50, 520–529.
17Neuhouser, ML, Rock, CL, Kristal, AR, et al. (2006) Olestra is associated with slight reductions in serum carotenoids but does not markedly influence serum fat-soluble vitamin concentrations. Am J Clin Nutr 83, 624–631.
18Colgan, HA, Floyd, S, Noone, EJ, et al. (2004) Increased intake of fruit and vegetables and a low-fat diet, with and without low-fat plant sterol-enriched spread consumption: effects on plasma lipoprotein and carotenoid metabolism. J Hum Nutr Diet 17, 561–569.
19Broekmans, WMR, Klopping-Ketelaars, IA, Weststrate, JA, et al. (2003) Decreased carotenoid concentrations due to dietary sucrose polyesters do not affect possible markers of disease risk in humans. J Nutr 133, 720–726.
20de Jong, A, Plat, J, Lütjohann, D, et al. (2008) Effects of long-term plant sterol or stanol ester consumption on lipid and lipoprotein metabolism in subjects on statin treatment. Br J Nutr 100, 937–941.
21Berendschot, TTJM & van Norren, D (2004) Objective determination of the macular pigment optical density using fundus reflectance spectroscopy. Arch Biochem Biophys 430, 149–155.
22Zagers, NPA, van de, KJ, Berendschot, TTJM, et al. (2002) Simultaneous measurement of foveal spectral reflectance and cone-photoreceptor directionality. Appl Opt 41, 4686–4696.
23Cooper, DA, Curran-Celentano, J, Ciulla, TA, et al. (2000) Olestra consumption is not associated with macular pigment optical density in a cross-sectional volunteer sample in Indianapolis. J Nutr 130, 642–647.
24Broekmans, WMR, Berendschot, TTJM, Klöpping, WA, et al. (2002) Macular pigment density in relation to serum and adipose tissue concentrations of lutein and serum concentrations of zeaxanthin. Am J Clin Nutr 76, 595–603.
25Hammond, BR, Curran-Celentano, J, Judd, S, et al. (1996) Sex differences in macular pigment optical density: relation to plasma carotenoid concentrations and dietary patterns. Vision Res 36, 2001–2012.
26Hammond, BR & Caruso-Avery, M (2000) Macular pigment optical density in a Southwestern sample. Invest Ophthalmol Vis Sci 41, 1492–1497.
27Ciulla, TA, Curran-Celentano, J, Cooper, DA, et al. (2001) Macular pigment optical density in a midwestern sample. Ophthalmology 108, 730–737.
28Johnson, EJ, Hammond, BR, Yeum, KJ, et al. (2000) Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr 71, 1555–1562.
29Burke, JD, Curran-Celentano, J & Wenzel, AJ (2005) Diet and serum carotenoid concentrations affect macular pigment optical density in adults 45 years and older. J Nutr 135, 1208–1214.